| Literature DB >> 34647157 |
Yulin Deng1, Hao Jiang1, Xiaoqiong Li1, Xuefei Lv2.
Abstract
Conventional lateral flow assay (LFA) is typically performed by observing the color changes in the test lines by naked eyes, which achieves considerable commercial success and has a significant impact on the fields of food safety, environment monitoring, disease diagnosis, and other applications. However, this qualitative detection method is not very suitable for low levels of disease biomarkers' detection. Although many nanomaterials are used as new labels for LFA, additional readers limit their application to some extent. Fortunately, a lot of work has been done for improving the sensitivity of LFA. In this review, currently reported LFA sensitivity enhancement methods with an objective evaluation are summarized, such as sample pretreatment, the change of flow rate, and label evolution, and future development direction and challenges of LFAs are discussed.Entities:
Keywords: Lateral flow assay; Sensitivity enhancement; Signal amplification
Year: 2021 PMID: 34647157 PMCID: PMC8513549 DOI: 10.1007/s00604-021-05037-z
Source DB: PubMed Journal: Mikrochim Acta ISSN: 0026-3672 Impact factor: 5.833
Fig. 1Sensitivity enhancement based on isothermal nucleic acid amplification. A Schematic illustration of RCA integrated with LFA for miRNA detection [35]. B Layout of the PDMS/paper hybrid microfluidic device integrated with on-chip LAMP system [51]. C The whole process for STOPCovid, Version 2 (STOPCovid.v2) Test [52]
Fig. 2Sensitivity enhancement based on sample enrichment. A Paper-based ICP pre-concentrators integrated with LFA for β-hCG detection [71]. B Experimental setup for (a) ITP-enhanced LFA and (b) conventional LFA. (c) Experimental snapshots were taken at 5 different time points [72]. C The 3-D paper is well combined with ATPS and LFA for transferrin detection [73]. (a) The 3-D paper well device was combined with a transferrin competition assay on nitrocellulose paper. Samples containing no transferrin were correctly diagnosed when using the (b) 1:1 or (c) 9:1 volume ratio of ATPS solutions. D Schematic of the integrated device of the semi-permeable membrane, glass fiber, and PEG buffer into with LFA [74]
Fig. 3Mechanism of magnetic fluorescence-based LFA platform for CEA and CA153 detection [81]
Fig. 4Sensitivity enhancement based on flow block. A (a)SEM image for the transversal cut of wax pillars area on LFA. (b) Surface profile roughness of LFA modified with wax pillars. (c) Schematic of a transversal cut of pillars zone on nitrocellulose membrane [86]. B Sensitivity enhancement in LFA by creating a PDMS barrier. (a) Effects of PDMS droplets numbers on LOD. (b) Results of flow velocity simulation of LFA [87]. C Schematic diagram of fluidic control in a paper–agarose hybrid material–based LFA [88]
Fig. 5Sensitivity enhancement based on NC membrane size change [92]. A Schematic of the flow path constriction device (a) and a standard lateral flow device (b). B Schematic of the modified laser-based direct-write procedure
Fig. 6Sensitivity enhancement based on colorimetric methods. A Dual AuNPs LFA was used for cTnI detection; the sizes of AuNPs were 10 nm and 40 nm, respectively [96]. B Schematic of a hybrid nanofiber-deposited LFA kit and the time-dependent changes of the conjugate pad (P), electrospun nanofibers E, test line (T), and control line C during the signal-enhanced assay [102]. C Expected effects of silver staining on LFA sensitivity enhancement [103]. D (Left) Results of LFA for different concentrations of human IgG and the different substrates. (Right) Results were obtained with the strip reader [90]. E Schematic of AuNP-assisted signal amplification on LFA for pathogen detection [104]. F (a) Schematic of EASE. (b) The relationship between dopamine accumulation and time in the presence of HRP [105]
Fig. 7Sensitivity enhancement based on SERS. A Schematic illustration of the core–shell SERS nanotag–based multiplex LFA for three cardiac biomarkers detection [121]. B Schematic illustration of quantitative LFA for three cardiac biomarkers detection on a single T line with different roman dyes encoded core–shell SERS nanotags [124]. C Schematic illustration of the principle of SERS paper-based lateral flow strip (PLFS) based on HGN [125]. (a) Top and side views; (b) side view before and after detection of protein biomarker; (c) optical results of PLFS assembled in cassettes in the presence (upper) and absence (bottom) of the target protein
Fig. 8Sensitivity enhancement based on the photothermal method. A Schematic of PT-ICSs [128]. (a) Preparation of BP-Au-Ab photothermal-sensing probe. (b) Structure and procedures of PT-ICSs. (c) Comparison of colorimetric results with photothermal results. B Principle of thermal contrast for LFA [129]. C Schematic of the PT-LSI sensor [130]. (a) A 780-nm light illuminated the NC membrane of LFA. (b) The absorbed light energy was converted into heat, and the resultant temperature increase altered the speckle pattern. (c) Exemplary speckle images before (green) and after (blue) photothermal illumination
Comparison of sensitivity enhancing effect of LFA based on different principles
| Method | Labels | LOD | Promotion degree | Advantages | Disadvantages | References |
|---|---|---|---|---|---|---|
| Isothermal nucleic acid amplification based | AuNPs | Single copy or lower 10 copies | / | Sensitivity | Enzyme inactivation | [ |
| Electrophoresis based | AuNPs | ng or pg/mL level | One or two order of magnitude | Without substances interference | Equipment dependent | [ |
| Extraction based | AuNPs | ng or pg/mL | An order of magnitude | Without substances interference | Non-portable | [ |
| Dialysis based | AuNPs | ng or pg/mL level | An order of magnitude | Without substances interference | Equipment dependent | [ |
| Magnetic enrichment based | AuNPs | ng or pg/mL level | An order of magnitude | Without substances interference and easy to separate | Expensive for functional magnet based | [ |
| Dual AuNPs based | AuNPs | ng or pg/mL level | An order of magnitude | Low cost, rapidness, easy to operation, and naked-eye readout | Disability to quantification, low sensitivity | [ |
| Silver staining based | AuNPs, AgNPs | ng or pg/mL level | An order of magnitude | Low cost, rapidness, and naked-eye readout | Multiple steps, low sensitivity | [ |
| Enzymatic amplification based | AuNPs | ng or pg/mL level | An order of magnitude | Low cost, rapidness, and naked-eye readout | Multiple steps, enzyme inactivation | [ |
| SERS based | MGITC, rhodamine B, rhodamine 6 G Nile blue A, methylene blue | Close to fg/mL level | 3–4 orders of magnitude | Sensitivity, rapidness, and quantification | Equipment dependent | [ |
| Photothermal illumination based | AuNPs | Close to fg/mL level | 3–4 orders of magnitude | Sensitivity, rapidness, and quantification | Equipment dependent | [ |